Cocrystal Pharma Inc. Stock
Cocrystal Pharma Inc. Stock
With 6 Buy predictions and not the single Sell prediction the community is currently very high on Cocrystal Pharma Inc..
Based on the current price of 1.4 € the target price of 10 € shows a potential of 614.29% for Cocrystal Pharma Inc. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Cocrystal Pharma Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Innovation" there were negative voices in the community.
Pros and Cons of Cocrystal Pharma Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cocrystal Pharma Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Cocrystal Pharma Inc. | - | 1.449% | 7.692% | -38.596% | -9.677% | -88.333% | - |
Gritstone Oncology Inc | 13.680% | 16.156% | -19.102% | -60.022% | -52.018% | -88.090% | - |
Avid Bioservices Inc | 0.700% | 5.109% | 24.138% | -55.556% | 18.033% | -60.000% | 78.174% |
Pacira Pharmaceuticals | 3.310% | 4.167% | -3.101% | -39.614% | -16.107% | -50.000% | -41.038% |
Comments
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Show more
Ratings data for COCP provided by MarketBeat
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Show more
Ratings data for COCP provided by MarketBeat
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its price target lowered by analysts at HC Wainwright from $12.00 to $10.00. They now have a "buy" rating on the stock.
Show more
Ratings data for COCP provided by MarketBeat